Latest News & Features
Americas
US-based law firm Offit Kurman has boosted its expertise in Virginia with the appointment of Christopher Raimund as a principal in the intellectual property practice. 5 January 2017
Americas
Par Pharmaceutical has sought a declaratory judgment that it did not infringe patents belonging to Sumitomo and its subsidiary Sunovion that protect bipolar disorder drug Latuda. 5 January 2017
Americas
IP law has yet to catch up with the technological capabilities of 3D printing, but by taking pre-emptive action, companies can maximise their IP protection under the current legal framework. Arlene Chow and Nitya Anand of Hogan Lovells report. 5 January 2017
Americas
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid. 4 January 2017
Americas
Amgen secured victory yesterday as a US federal judge refused to throw out a ruling upholding the validity of two patents owned by the company. 4 January 2017
Americas
Intellectual property law firm Fitzpatrick, Cella, Harper & Scinto has appointed Susanne Flanders, Natalie Lieber and Dennis McMahon as partners in the firm. 4 January 2017
Americas
Healthcare company Abbott Laboratories has agreed to divest two medical device businesses in a bid to settle competition charges brought by the US Federal Trade Commission. 3 January 2017
Americas
Sanofi, and its subsidiary Genzyme, has targeted two pharmaceutical companies in patent lawsuits related to its drug Aubagio. 3 January 2017
Big Pharma
It appears necessary and perhaps inevitable that further guidance from the UK Court of Appeal will be provided on the issue of second medical use patents, following the high-profile dispute between Warner-Lambert and Actavis. Geoff Hussey and Christopher Burnett of AA Thornton & Co report. 3 January 2017
Asia-Pacific
A report released by the Australian government has said Australia's extension of term scheme for patents in the pharmaceutical industry "has had little effect" on investment and innovation. 23 December 2016